📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes. (2025)

First Author: Henney AE
Attributed to:  Quantifying Artificial Pancreas-related Changes in Diabetic Neuropathy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/liv.70367

PubMed Identifier: 40980971

Publication URI: http://europepmc.org/abstract/MED/40980971

Type: Journal Article/Review

Volume: 45

Parent Publication: Liver international : official journal of the International Association for the Study of the Liver

Issue: 10

ISSN: 1478-3223